FIELD: medicine.
SUBSTANCE: pharmaceutical composition for suppression of cancer metastases in individual contains fibrillar protein and pharmaceutically acceptable excipient. Said fibrillar protein is selected from group, consisting of fibrillar albumin, fibrillar serum human albumin and fibrillar capsid proteins of foot-and-mouth disease virus. To prepare said composition human fibrillar serum albumin is obtained and mixed in therapeutically effective quantity with pharmaceutically acceptable carrier.
EFFECT: increased efficiency of suppressing cancer metastases.
11 cl, 1 tbl, 33 dwg, 12 ex
